Biomarin Pharmaceutical Inc.
0
0
0%

Statistics

Valuation metrics
Market cap
9.35B
Enterprise value
6.56B
Trailing P/E (ttm)
19.48
Forward P/E
PEG ratio
Price/Sales (ttm)
2.80
Price/Book (mrq)
1.66
Enterprise Value/Revenue
2.49
Enterprise Value/EBITDA
9.69
Overview
Shares outstanding
192.10M
Float
190.43M
Shares short
% Held by insiders
0.77%
% Held by institutions
98.00%
Average volume (10 days)
1
Average volume (90 days)
0
Price summary
52-Week low
44.02
52-Week high
69.12
52-Week change
-44.56
Beta
0.30
50-Day moving average
46.30
200-Day moving average
50.78
Financials
Fiscal year
Fiscal year ends
Dec 31, 2024
Most recent quarter (mrq)
Sep 30, 2025
Profitability
Profit margin
16.82%
Operating margin
-6.02%
Operational effectiveness
Return on assets
6.15%
Return on equity
9.07%
Income statement
Revenue (ttm)
2.64B
Revenue per share (ttm)
16.17
Quarterly revenue growth (yoy)
4.10%
Gross profit (ttm)
2.14B
EBITDA
545.89M
Net income to common (ttm)
443.53M
Diluted EPS (ttm)
2.29
Quarterly earnings growth (yoy)
2.60%
Balance sheet
Total cash (mrq)
1.26B
Total cash per share (mrq)
7.69
Total debt (mrq)
514.96M
Total Debt/Equity (mrq)
9.98
Current ratio (mrq)
482.80%
Book value per share (mrq)
26.86
Cash flow
Cash flow statement
778.94M
Levered free cash flow (LFCF)
384.83M
Access /statistics data via our API — starting from the Pro plan.
Main market

Exchange is currently active.
Closing in 6 hours 40 minutes

10:54
00:00
08:55
17:35
23:59

Trading Hours (Monday - Friday):

Pre-market
08:00 - 08:55
Main market
08:55 - 17:35
Post-market
17:35 - 17:50
All times are displayed in the Europe/Vienna timezone (CET, UTC+01:00).